Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

New paper by Centre for Tropical Medicine & Global Health researcher Rima Shretta, published in Malaria Journal, finds that lower donor support and COVID-19 lockdowns threaten 10 years of progress

A lab technician checks a blood sample for malaria © AMISOM photo / Tobin Jones, Public domain

Ghana cut malaria deaths by 65% from 2005 to 2015. In a paper published in the Malaria Journal, Rima Shretta estimates that the COVID-19 outbreak threatens this progress, as lockdowns limit access to health facilities and preventive malaria interventions have been interrupted. Ghana’s transition to a lower middle income status results in lower donor support for malaria control, and the government must step up to avert a feared rise in cases.

The full story is available on the Centre for Tropical Medicine & Global Health website

Similar stories

Oxford vaccine reaches one billion doses released

The University of Oxford’s and our partners AstraZeneca have today announced that one billion doses of the ChAdOx1 nCov-19 coronavirus vaccine have been released, to more than 170 countries, marking a key milestone as part of the University and AstraZeneca’s joint vision to make the available to the world, on a not-for-profit basis for the world during the pandemic, and in perpetuity for low- and middle-income countries.

Research programme tackling COVID-19 variants of concern receives funding boost

A gift from the Red Avenue Foundation will enable the expansion of a major research programme aimed at rapidly identifying and interrogating emerging COVID-19 variants.

Phase I trial begins of new vaccine against the Plague

Researchers at the University of Oxford today launched a Phase 1 trial to test a new vaccine against plague.

New therapeutic targets identified in the treatment of psoriatic arthritis

Researchers identify two inflammatory-driving proteins, osteopontin and CCL2, highly expressed in psoriatic arthritis joints.

Treatment choice for rotator cuff disorders could create efficiency and savings for the NHS

A trial that evaluated the clinical and cost effectiveness of physiotherapy treatments for rotator cuff disorders suggests cost savings can be made while maintaining positive patient outcomes.